EarningsQ2 2025 Earnings Report

Recursion Pharmaceuticals (RXRX) Q2 2025 Earnings Report

7 Followers

MX:RXRX Q2 2025 EPS Results

Actual EPS-$7.06

Consensus EPS-$6.08

Beat/MissMissed by -$0.98

One Year Ago EPS-$6.89

Actual Revenue$331.01M

Expected Revenue$264.61M

Beat/MissBeat by +$66.40M

YoY Revenue Growth+33.34%

QuarterQ2 2025

Date08/05/2025

TimeBefore Open

Conference CallTuesday, August 5, 2025

MX:RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:RXRX Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-3.79 / -	-6.199	―
Aug 05, 2026	2026 (Q2)	-4.13 / -4.30	-7.06	39.02% (+2.76)
May 06, 2026	2026 (Q1)	-4.56 / -3.79	-8.61	56.00% (+4.82)
Feb 25, 2026	2025 (Q4)	-5.18 / -3.62	-9.126	60.38% (+5.51)
Nov 05, 2025	2025 (Q3)	-6.49 / -6.20	-5.855	-5.88% (-0.34)
Aug 05, 2025	2025 (Q2)	-6.08 / -7.06	-6.888	-2.50% (-0.17)
May 05, 2025	2025 (Q1)	-8.89 / -8.61	-6.716	-28.21% (-1.89)
Feb 28, 2025	2024 (Q4)	-7.08 / -9.13	-7.232	-26.19% (-1.89)
Nov 06, 2024	2024 (Q3)	-5.73 / -5.85	-7.404	20.93% (+1.55)
Aug 08, 2024	2024 (Q2)	-6.61 / -6.89	-6.543	-5.26% (-0.34)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed